Abstract 3087: Targeting AURKA and TRIP13 exploits mitotic vulnerability and enhances antitumor immunity in Rb-deficient immunocompetent lung cancer models
Year: 2026
Type: conference-abstract
Source: Cancer Research
Institution: The University of Texas MD Anderson Cancer Center
Language: English
Subfield: Cell Biology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W7148746556
Cites:
Cited by:
Related to: